ZA200701363B - A method for preparing irbesartan and intermediates thereof - Google Patents

A method for preparing irbesartan and intermediates thereof

Info

Publication number
ZA200701363B
ZA200701363B ZA200701363A ZA200701363A ZA200701363B ZA 200701363 B ZA200701363 B ZA 200701363B ZA 200701363 A ZA200701363 A ZA 200701363A ZA 200701363 A ZA200701363 A ZA 200701363A ZA 200701363 B ZA200701363 B ZA 200701363B
Authority
ZA
South Africa
Prior art keywords
intermediates
preparing irbesartan
irbesartan
preparing
Prior art date
Application number
ZA200701363A
Other languages
English (en)
Inventor
Edgar I Miranda
Zhu Jingyang
Vlaar Cornelis
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA200701363B publication Critical patent/ZA200701363B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200701363A 2004-08-23 2007-02-15 A method for preparing irbesartan and intermediates thereof ZA200701363B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60360604P 2004-08-23 2004-08-23

Publications (1)

Publication Number Publication Date
ZA200701363B true ZA200701363B (en) 2008-06-25

Family

ID=35968277

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701363A ZA200701363B (en) 2004-08-23 2007-02-15 A method for preparing irbesartan and intermediates thereof

Country Status (21)

Country Link
US (2) US7211676B2 (xx)
EP (1) EP1781627B1 (xx)
JP (1) JP5203703B2 (xx)
KR (1) KR101252309B1 (xx)
CN (1) CN101006064B (xx)
AR (1) AR050709A1 (xx)
AT (1) ATE488508T1 (xx)
AU (1) AU2005277162B2 (xx)
BR (1) BRPI0514584A (xx)
CA (2) CA2578409A1 (xx)
DE (1) DE602005024819D1 (xx)
ES (1) ES2357393T3 (xx)
HK (1) HK1098157A1 (xx)
IL (1) IL181464A (xx)
MX (1) MX2007002030A (xx)
NO (1) NO20071254L (xx)
PE (1) PE20060650A1 (xx)
RU (1) RU2388753C2 (xx)
TW (1) TWI346108B (xx)
WO (1) WO2006023889A2 (xx)
ZA (1) ZA200701363B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918288A1 (en) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited A novel and improved process for the preparation of Irbesartan, an angiotensin-II receptor antagonist for the treatment of hypertension
GB0700993D0 (en) * 2007-01-18 2007-02-28 Rainbow Engineering Services Novel compounds
WO2008107799A2 (en) * 2007-03-06 2008-09-12 Actavis Group Ptc Ehf Improved process for preparing irbesartan
SI22488A (sl) * 2007-04-24 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalni 1-(cikloheksiloksikarboniloksi)etil 1-((2'-cianobifenil-4-il)metil) - 2-etoksi-1h-benz(d)imidazol -7-karboksilat in proces za njegovo pripravo
HUP0900788A2 (en) * 2009-12-16 2011-11-28 Sanofi Aventis Process for producing 4-bromomethyl-biphenyl derivatives
KR101409137B1 (ko) * 2010-03-12 2014-06-17 닛뽕소다 가부시키가이샤 피리딘 고리 함유 화합물, 및 할로겐화피콜린 유도체 및 테트라졸릴옥심 유도체의 제조 방법
CN102807564A (zh) * 2012-08-30 2012-12-05 珠海润都制药股份有限公司 厄贝沙坦的制备方法
CN102898420B (zh) * 2012-09-10 2014-10-29 珠海保税区丽珠合成制药有限公司 一种厄贝沙坦的合成路线及制备方法
CN103497178B (zh) * 2013-09-27 2015-04-08 中国药科大学 厄贝沙坦瑞格列奈共无定型物
CN104744303B (zh) * 2015-02-15 2017-06-23 北京欣奕华科技有限公司 2‑r‑4’‑溴甲基联苯及其制备方法
CN108164434A (zh) * 2017-12-27 2018-06-15 安徽太主科技发展有限公司 一种低成本4′-溴甲基-2-氰基联苯的制备方法
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237476A (en) 1990-03-20 1994-01-26 Sanofi Sa N-substituted heterocyclic compounds and pharmaceutical compositions.
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
US5541209A (en) * 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
FR2725987B1 (fr) * 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
JP3003030B2 (ja) * 1997-05-26 2000-01-24 武田薬品工業株式会社 アミノベンゼン化合物の製造法
FR2766821A1 (fr) 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
CN100418962C (zh) * 2002-10-28 2008-09-17 南京长澳医药科技有限公司 一种厄贝沙坦合成工艺
DE602004014321D1 (de) * 2003-01-16 2008-07-24 Teva Pharma Neue synthese von irbesartan

Also Published As

Publication number Publication date
ES2357393T3 (es) 2011-04-26
JP5203703B2 (ja) 2013-06-05
RU2388753C2 (ru) 2010-05-10
US7211676B2 (en) 2007-05-01
US20070167634A1 (en) 2007-07-19
MX2007002030A (es) 2007-03-28
US20060041147A1 (en) 2006-02-23
DE602005024819D1 (de) 2010-12-30
HK1098157A1 (en) 2007-07-13
EP1781627A2 (en) 2007-05-09
EP1781627A4 (en) 2009-09-02
EP1781627B1 (en) 2010-11-17
CN101006064A (zh) 2007-07-25
IL181464A (en) 2011-08-31
NO20071254L (no) 2007-03-22
TWI346108B (en) 2011-08-01
IL181464A0 (en) 2007-07-04
WO2006023889A3 (en) 2006-09-08
AU2005277162A1 (en) 2006-03-02
JP2008510819A (ja) 2008-04-10
CA2578409A1 (en) 2006-03-02
CA2754633A1 (en) 2006-03-02
PE20060650A1 (es) 2006-07-09
KR101252309B1 (ko) 2013-04-08
AU2005277162B2 (en) 2010-12-16
KR20070045275A (ko) 2007-05-02
US7365208B2 (en) 2008-04-29
ATE488508T1 (de) 2010-12-15
BRPI0514584A (pt) 2008-06-17
TW200619205A (en) 2006-06-16
AR050709A1 (es) 2006-11-15
RU2007109330A (ru) 2008-09-27
WO2006023889A2 (en) 2006-03-02
CN101006064B (zh) 2011-01-26

Similar Documents

Publication Publication Date Title
TWI346108B (en) A method for preparing irbesartan and intermediates thereof
IL183091A0 (en) Method for preparing n-phenylpyrazole-1-carboxyamides
IL210906A0 (en) Method for providing a slurry
IL180247A0 (en) Method for producing 4-
IL177233A0 (en) Method for producing polyisobutenylphenols
PT1713756E (pt) Processo para a preparação de dinitrotolueno
PL1831223T3 (pl) Sposób wytwarzania L-biopteryny
GB0402639D0 (en) Method
GB0406102D0 (en) A casting method
GB0422378D0 (en) A method
GB0410103D0 (en) New method
HK1099931A1 (en) Synthesising method and benzoxathiepine intermediates
GB0405751D0 (en) Method
TWI315261B (en) Method for transferring-printing
SG136139A1 (en) Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
PL366494A1 (en) Method for obtaining 5-nitroguaiacol
GB0400756D0 (en) Method of detroying a document
IL191074A0 (en) A method for preparing liposomes and uses thereof
GB0405777D0 (en) Method of forming a part
TJ16Y3 (en) A method for total vestibuboplastic of the top jawat adentia
PL372042A1 (pl) Sposób otrzymywania 3-chloropropyloorganosilanów
PL368361A1 (en) Method for obtaining tetrafluorethane-beta-sultone
PL370755A1 (pl) Sposób otrzymywania dibutyrylochityny
PL368794A1 (pl) Sposób otrzymywania dichloropropanoli
PL367119A1 (en) Method for obtaining beta-metylglycidol